118 related articles for article (PubMed ID: 2065719)
61. Caramiphen, iodocaramiphen and nitrocaramiphen are potent, competitive, muscarinic M1 receptor-selective agents.
Hudkins RL; Stubbins JF; DeHaven-Hudkins DL
Eur J Pharmacol; 1993 Feb; 231(3):485-8. PubMed ID: 8449241
[TBL] [Abstract][Full Text] [Related]
62. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
[TBL] [Abstract][Full Text] [Related]
63. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
64. M1 and M3 muscarinic receptors: specific roles in sleep regulation.
Imeri L; Bianchi S; Angeli P; Mancia M
Neuroreport; 1992 Mar; 3(3):276-8. PubMed ID: 1515585
[TBL] [Abstract][Full Text] [Related]
65. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
66. PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.
Michel AD; Stefanich E; Whiting RL
Br J Pharmacol; 1989 Jul; 97(3):914-20. PubMed ID: 2758243
[TBL] [Abstract][Full Text] [Related]
67. The (S)-(+)-enantiomer of dimethindene: a novel M2-selective muscarinic receptor antagonist.
Pfaff O; Hildebrandt C; Waelbroeck M; Hou X; Moser U; Mutschler E; Lambrecht G
Eur J Pharmacol; 1995 Nov; 286(3):229-40. PubMed ID: 8608784
[TBL] [Abstract][Full Text] [Related]
68. Muscarinic acetylcholine receptors in the brain of the zebrafish (Danio rerio) measured by radioligand binding techniques.
Williams FE; Messer WS
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Apr; 137(4):349-53. PubMed ID: 15228953
[TBL] [Abstract][Full Text] [Related]
69. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
70. H3-receptor activation inhibits cholinergic stimulation of acid secretion in isolated rabbit fundic glands.
Bado A; Laigneau JP; Moizo L; Cherifi Y; Lewin MJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1099-103. PubMed ID: 8531069
[TBL] [Abstract][Full Text] [Related]
71. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
72. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
Aubert I; Cécyre D; Gauthier S; Quirion R
Eur J Pharmacol; 1992 Jul; 217(2-3):173-84. PubMed ID: 1425938
[TBL] [Abstract][Full Text] [Related]
73. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U
J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904
[TBL] [Abstract][Full Text] [Related]
74. Muscarinic receptor subtype mediating vasodilation feline middle cerebral artery exhibits M3 pharmacology.
Dauphin F; Hamel E
Eur J Pharmacol; 1990 Mar; 178(2):203-13. PubMed ID: 2328761
[TBL] [Abstract][Full Text] [Related]
75. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
Sallés J; Wallace MA; Fain JN
J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
[TBL] [Abstract][Full Text] [Related]
76. Muscarinic acetylcholine receptor subtypes in the rat seminal vesicle.
Hamamura M; Maróstica E; de Avellar MC; Porto CS
Mol Cell Endocrinol; 2006 Mar; 247(1-2):192-8. PubMed ID: 16481100
[TBL] [Abstract][Full Text] [Related]
77. Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.
Brunner F; Waelbroeck M; Christophe J
Eur J Pharmacol; 1986 Aug; 127(1-2):17-25. PubMed ID: 3758175
[TBL] [Abstract][Full Text] [Related]
78. In vitro pharmacological properties of 4-bromodexetimide for muscarinic receptors.
Strijckmans V; Coulon C; Kassiou M; Loc'h C; Mazière B
Life Sci; 1996; 58(23):PL337-44. PubMed ID: 8649190
[TBL] [Abstract][Full Text] [Related]
79. Stereoselective interaction of uncharged esters at four muscarinic receptor subtypes.
Waelbroeck M; Hou X; Wehrle J; Mutschler E; Van Tilburg E; Menge W; Timmerman H; Lambrecht G
Eur J Pharmacol; 1996 May; 303(3):221-6. PubMed ID: 8813573
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head.
Angeli P; Brasili L; Cingolani ML; Marucci G; Piergentili A; Pigini M; Quaglia W
Bioorg Med Chem; 1997 Apr; 5(4):731-7. PubMed ID: 9158872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
